Skip to main content
. 2014 Feb 4;9(2):e87864. doi: 10.1371/journal.pone.0087864

Table 6. Predicted results with evidence supported at an EASE score≤10−5.

Drug-indication pairs Number Percentage
FDA-approved 1336 71.91%
Clinical 132 7.10%
Preclinical 32 1.72%
Unknown 358 19.27%
HHS Vulnerability Disclosure